Pantouvaki Anna, Kastanis Grigorios, Patelarou Evridiki, Alpantaki Kalliopi, Kleisiaris Christos, Zografakis-Sfakianakis Michail
Department of Nursing, School of Health Sciences, Hellenic Mediterranean University, 71410 Heraklion, Greece.
Department of Physiotherapy, General Hospital, "Venizeleio-Pananeio", 71409 Heraklion, Greece.
Nurs Rep. 2023 Mar 3;13(1):404-411. doi: 10.3390/nursrep13010037.
Sarcopenia is a progressive aging syndrome with severe socioeconomic costs. Therefore, the early diagnosis of sarcopenia is required to secure early treatment and to enhance quality of life. The Mini Sarcopenia Risk Assessment (MSRA) questionnaire, which is available in seven-item (MSRA-7) and five-item (MSRA-5) versions, is a sarcopenia screening tool that was translated into Greek, adapted, and validated in this study. The present study was developed in an outpatient hospital setting, from April 2021 to June 2022. The MSRA-7 and MSRA-5 questionnaires were translated backwards and forwards and adapted to the Greek language. To validate the MSRA questionnaire as a pre-screening tool to identify the risk of sarcopenia in the older Greek population, both the MSRA-7 and MSRA-5 versions were correlated with the Greek version of the SARC-F questionnaire, which is a widely accepted and well-known tool used in sarcopenia screening. Ninety elderly subjects aged 65-89 years-old with no mobility impairments participated in this study. The questionnaires' content validity was assessed using the Content Validity Ratio, and the Content Validity Index was calculated for the instrument. The intra-rater reliability was assessed by calculating the Intra-class Correlation Coefficient between the initial assessment and the reassessment of the MSRA questionnaire, which was 0.986, with a 95% Confidence Interval of 0.961-0.995. Concurrent validity was assessed between the Greek MSRA questionnaires and the SARC-F questionnaire using the Spearman's rank correlation coefficient (p). The Greek MSRA-7 questionnaire had a very high correlation with the SARC-F questionnaire (rho = -0.741, < 0.001), as did the Greek MSRA-5 questionnaire (rho = -0.724, < 0.001). The proofs of content validity, concurrent validity, and intra-rater reliability provided for the Greek versions of the MSRA, designated them as reliable pre-screening tools for the detection of sarcopenia in the older population and in clinical practice.
肌肉减少症是一种具有严重社会经济成本的进行性衰老综合征。因此，需要对肌肉减少症进行早期诊断，以确保早期治疗并提高生活质量。迷你肌肉减少症风险评估（MSRA）问卷有七项（MSRA-7）和五项（MSRA-5）两个版本，是一种肌肉减少症筛查工具，本研究将其翻译成希腊语、进行了改编并验证。本研究于2021年4月至2022年6月在一家门诊医院开展。MSRA-7和MSRA-5问卷进行了双向翻译并改编成希腊语。为了验证MSRA问卷作为一种预筛查工具来识别希腊老年人群中肌肉减少症的风险，MSRA-7和MSRA-5版本均与SARC-F问卷的希腊语版本相关联，SARC-F问卷是一种在肌肉减少症筛查中广泛接受且知名的工具。90名年龄在65 - 89岁且无行动障碍的老年受试者参与了本研究。使用内容效度比评估问卷的内容效度，并计算该工具的内容效度指数。通过计算MSRA问卷初始评估和重新评估之间的组内相关系数来评估评分者内信度，其值为0.986，95%置信区间为0.961 - 0.995。使用斯皮尔曼等级相关系数（p）评估希腊语MSRA问卷和SARC-F问卷之间的同时效度。希腊语MSRA-7问卷与SARC-F问卷具有非常高的相关性（rho = -0.741，p < 0.001），希腊语MSRA-5问卷也是如此（rho = -0.724，p < 0.001）。为希腊语版本的MSRA提供的内容效度、同时效度和评分者内信度的证据，将它们指定为在老年人群和临床实践中检测肌肉减少症的可靠预筛查工具。
